Akero Therapeutics Inc (AKRO)

Akero Therapeutics (AKRO) Financial Statements


Akero Therapeutics Financial Overview

Akero Therapeutics's market cap is currently ―. The company's EPS TTM is $-3.202; its P/E ratio is -8.65; Akero Therapeutics is scheduled to report earnings on August 13, 2024, and the estimated EPS forecast is $-0.83. See an overview of income statement, balance sheet, and cash flow financials.
Mar 24Dec 23Sep 23Jun 23Mar 23
Income Statement-
Total Revenue-----
Gross Profit-----
EBIT$ -52.35M$ -54.29M$ -39.03M$ -30.50M$ -25.39M
EBITDA$ -52.35M$ -54.29M$ -42.17M$ -31.75M$ -26.55M
Net Income Common Stockholders$ -53.34M$ -55.19M$ -39.91M$ -31.08M$ -25.85M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 903.66M$ 550.01M$ 554.73M$ 639.44M$ 343.22M
Total Assets$ 912.24M$ 580.27M$ 635.33M$ 663.81M$ 348.78M
Total Debt$ 35.55M$ 25.78M$ 25.73M$ 25.68M$ 25.63M
Net Debt$ -868.11M$ -524.23M$ -529.00M$ -613.76M$ -317.59M
Total Liabilities$ 65.99M$ 44.97M$ 52.20M$ 47.37M$ 42.47M
Stockholders Equity$ 846.25M$ 535.31M$ 583.13M$ 616.44M$ 306.35M
Cash Flow-
Free Cash Flow$ -35.14M$ -48.63M$ -49.72M$ -22.39M$ -24.63M
Operating Cash Flow$ -35.14M$ -48.63M$ -49.72M$ -22.39M$ -24.63M
Investing Cash Flow$ 57.85M$ 12.79M$ -125.70M$ -128.30M$ 17.59M
Financing Cash Flow$ 366.94M$ 502.00K$ 806.00K$ 336.86M$ 15.15M
Currency in USD

Akero Therapeutics Earnings and Revenue History

Akero Therapeutics Debt to Assets

Akero Therapeutics Cash Flow

Akero Therapeutics Forecast EPS vs Actual EPS

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis